DocSym
β
Searchsearch
Search
(Y54.2) Carbonic-anhydrase inhibitors
More details coming soon
23 983 in individuals diagnosis carbonic-anhydrase inhibitors confirmed
1 816 deaths with diagnosis carbonic-anhydrase inhibitors
8% mortality rate associated with the disease carbonic-anhydrase inhibitors
Diagnosis carbonic-anhydrase inhibitors is diagnosed Women are 44.36% more likely than Men
6 672
Men receive the diagnosis carbonic-anhydrase inhibitors
1 476 (22.1 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
17 311
Women receive the diagnosis carbonic-anhydrase inhibitors
340 (2.0 %)Died from this diagnosis.
Risk Group for the Disease carbonic-anhydrase inhibitors - Men aged 25-29 and Women aged 65-69
In Men diagnosis is most often set at age 0-5, 25-29, 45-49, 55-59, 70-84
Less common in men the disease occurs at Age 0-1, 5-24, 30-44, 50-54, 60-69, 85-95+Less common in women the disease occurs at Age 0-59, 85-94
In Women diagnosis is most often set at age 60-84, 95+
Disease Features carbonic-anhydrase inhibitors
Absence or low individual and public risk
Carbonic-anhydrase inhibitors - what does this mean
Carbonic-anhydrase inhibitors are medications that work by blocking the enzyme carbonic anhydrase, which is responsible for the production of bicarbonate ions in the body. this leads to a decrease in the production of carbon dioxide, which in turn helps to reduce the pressure inside the eye and can be used to treat glaucoma.
What happens during the disease - carbonic-anhydrase inhibitors
Carbonic-anhydrase inhibitors are drugs that inhibit the enzyme carbonic anhydrase, which is responsible for the hydration of carbon dioxide and the conversion of carbon dioxide and water into bicarbonate ions. when carbonic anhydrase inhibitors are used, the hydration of carbon dioxide is inhibited, resulting in an increase in the amount of carbon dioxide in the body. this increase in carbon dioxide can lead to an increase in acidity in the body, which can cause a variety of complications, including metabolic acidosis, increased intracranial pressure, and an increased risk of kidney stones.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Laboratory tests
- Imaging studies
- Endoscopy
- Biopsy
- Genetic testing
- Carbonic-anhydrase inhibitors testing
Treatment and Medical Assistance
Main Goal: Treating Carbonic-Anhydrase Inhibitors
- Prescribe medications to reduce symptoms
- Perform regular physical examinations
- Administer oxygen therapy
- Monitor blood pressure and electrolyte levels
- Prescribe diuretics to reduce fluid retention
- Prescribe anti-inflammatory medications
- Provide dietary and lifestyle advice
- Provide psychological support
- Refer to specialist for further treatment
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Carbonic-anhydrase inhibitors - Prevention
The best way to prevent carbonic-anhydrase inhibitors is to avoid exposure to environmental toxins, abstain from smoking, and maintain a healthy diet and lifestyle. additionally, it is important to be aware of any potential side effects of medications that may increase the risk of developing carbonic-anhydrase inhibitors and to consult with a doctor if any symptoms arise.